Breaks Categories: Stock Spotlights

WednesdayNov 16, 2016 12:49 pm

Amyris, Inc. (AMRS) Collaboration Reaches “Key Milestone” in Oncology Drug Development

Amyris (NASDAQ: AMRS) shares are ticking higher after the industrial bioscience company said its collaboration with “one of the world’s leading” pharmaceutical companies has resulted in the creation of a “robust, sensitive activity assay for an oncology target in a live yeast strain.” This high-throughput assay enables screening for chemical diversity found in nature using Amyris’s proprietary µPharm™ platform, with the potential to provide previously inaccessible molecule targets. The µPharm platform combines two powerful technologies that Amyris said can significantly accelerate and reduce the cost of new drug discovery. To view the full press release, visit: http://nnw.fm/9LkVH About Amyris Amyris…

Continue Reading

TuesdayNov 15, 2016 1:09 pm

Marathon Patent Group, Inc. (MARA) Subsidiary Inks Licensing Deal with the University of Cincinnati; Shares Lower

3D Nanocolor Corporation, a subsidiary of Marathon Patent Group (NASDAQ: MARA), has entered into an exclusive license agreement with the University of Cincinnati covering the company’s patent-pending applications based on 3D Nanocolor's electrokinetic (EK) technology. 3D Nanocolor will showcase a prototype of the technology early next year. "The recent addition of two highly capable and accomplished technologists with specific experience in our field of technology, combined with our prototype of our technology being showcased to executives of a leading European automobile manufacturer in early 2017, gives us cause for optimism. We are working diligently and looking forward to the opportunity…

Continue Reading

TuesdayNov 15, 2016 11:33 am

Fusion Telecommunications (FSNN) Trades Higher on Apptix Acquisition, Q3 Performance, New Credit Facility

Shares of Fusion Telecommunications (NASDAQ: FSNN) are 10% higher after the company announced its acquisition of Virginia-based cloud services provider Apptix, Inc. for $28 million, as well as reported third-quarter revenue of $29.5 million and a $70 million credit facility. Fusion attributes the 20% YoY increase in consolidated revenue to revenue growth of 27% from its Business Services segment. To view the full press release, visit: http://nnw.fm/0zz9C About Fusion Fusion, a leading provider of integrated cloud solutions to small, medium and large businesses, is the industry's single source for the cloud. Fusion's advanced, proprietary cloud service platform enables the integration…

Continue Reading

MondayNov 14, 2016 12:03 pm

FDA Response Triggers Dynavax Technologies (DVAX) Sell-off

Dynavax Technologies (NASDAQ: DVAX) is down more than 60% mid-morning after the company said it received a Complete Response Letter (CRL) from the FDA regarding its Biologics License Application (BLA) for its HEPLISAV-B™ vaccine against hepatitis B infection. The CRL signals the FDA’s completed a review of an application and stands as a request for additional information for review and approval. Dynavax said it expects a Class 2 designation for a resubmission of the BLA, which would result in a target review period of six months. To view the full press release, visit: http://nnw.fm/9mS6x About Dynavax Dynavax, a clinical-stage biopharmaceutical…

Continue Reading

MondayNov 14, 2016 12:00 pm

National Waste Management Holdings, Inc. (NWMH) is Active Participant in Florida’s Statewide Recycling Initiative

The State of Florida is working toward a statewide recycling goal of 75% by the year 2020. The journey to such a high bar is a lengthy one. While the state’s recycling rate increased by 4% between 2012 and 2013, the amount of solid waste has also increased, from just under 28 million tons to over 30 million. Florida’s Department of Environmental Protection believes that more commercial recycling would help reach its goal of 75%, and National Waste Management Holdings, Inc. (OTC: NWMH) is addressing the challenge head on. Reporting third-quarter revenue growth of 269%, National Waste employs a strategic…

Continue Reading

FridayNov 11, 2016 1:11 pm

Towerstream Corp. (TWER) Increases Q3 Adjusted EBITDA; Shares Higher

Shares of Towerstream (NASDAQ: TWER) are higher in late-morning trade, driven by third-quarter guidance for Adjusted EBITDA from Continuing Operations of $525,000 excluding non-recurring expenses. Among other notes, the company reported a reduction in long-term debt to $32 million from $37 million. A conference call to discuss results for the third quarter 2016 will be held November 16, 2016 at 5 p.m. ET. To view the full press release, visit: http://nnw.fm/vKlW9 About Towerstream Corporation Towerstream Corporation (TWER) is a leading Fixed-Wireless Fiber Alternative company delivering high-speed Internet access to businesses. The Company offers broadband services in 12 urban markets including New York City, Boston,…

Continue Reading

FridayNov 11, 2016 1:10 pm

GainClients, Inc. (GCLT) Targets Emerging Digital Trends in Real Estate Industry

GainClients’ (OTC: GCLT) progressive GCard networking system enables agents and brokers the ability to offer real estate, lending and title services information through an integrated, web-based network, capitalizing on the ongoing shift in consumer preference toward mobile solutions. As the company pursues avenues to expand the reach of its GCard network, it employs a growth strategy supported by key industry partnerships and licensing arrangements. “Strategic partnerships are an important component of GainClients’ growth strategy. The company recently established a worldwide licensing arrangement with CLOVIS LLC, a partnership that will enable the distribution of both companies’ proprietary technologies to the real…

Continue Reading

FridayNov 11, 2016 1:08 pm

Medical Transcription Billing, Corp. (MTBC) Provides Essential Element of Broader Health Care Initiatives

Considered by some to be the most important piece of health care reform in three decades, The Health Information Technology for Economic and Clinical Health (HITECH) Act of 2009, among other things, encouraged the use of electronic health records (EHR) to significantly improve medical services. Integrated charting services are a core part of Medical Transcription Billing, Corp.’s (NASDAQ: MTBC) (NASDAQ: MTBCP) proprietary HER technology, ChartsPro, which makes the delivery of service more efficient and enables practitioners to reach ‘Meaningful Use’ standards set forth by HITECH. “MTBC’s charting services are designed to help physicians generate accurate, timely patient charts and better…

Continue Reading

ThursdayNov 10, 2016 2:04 pm

Imprimis Pharmaceuticals, Inc. (IMMY) Inks New Supply Agreement; Shares Climb

Imprimis Pharmaceuticals (NASDAQ: IMMY) is trading 11% higher mid-morning, driven by the company’s product purchase and supply agreement with the specialty pharmacy division of one of the nation's largest pharmacy benefit managers (PBMs) to supply Imprimis' complete formulary of low-cost compounded medications through the PBM's national network of specialty pharmacies. To view the full press release, visit: http://nnw.fm/Y7hHj About Imprimis Pharmaceuticals Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) is a pharmaceutical company dedicated to producing and dispensing high quality innovative compounded medications in all 50 states.  The company's unique business model drives patient access and affordability to many critical medicines.  Headquartered in…

Continue Reading

ThursdayNov 10, 2016 10:58 am

Galectin Therapeutics, Inc. (GALT) Shares Surge on Positive Interim Data for Lead Candidate GR-MD-02

Shares of Galectin Therapeutics (NASDAQ: GALT) are up more than 30% this morning after delivering positive interim clinical data for its lead candidate GR-MD-02 to treat psoriasis and atopic dermatitis. The company also announced its plans to identify a strategic partnership to further develop the drug candidate for the treatment of serious skin diseases. To view the full press release, visit: http://nnw.fm/d95Ap About Galectin Therapeutics Galectin Therapeutics is developing promising carbohydrate-based therapies for the treatment of fibrotic liver disease and cancer based on the Company's unique understanding of galectin proteins, which are key mediators of biologic function. Galectin seeks to…

Continue Reading